Please login to the form below
RandD productivity
This page shows the latest RandD productivity news and features for those working in and with pharma, biotech and healthcare.
COVID-19 Updates and Daily News
Featured jobs
- Group Account Director, Patient Engagement & Solutions, Lond...
-
Highly competitive salary
- Account Director, Publications, Opthalmology, Medical Communicat...
-
Highly competitive salary
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
-
Publications Director
-
Competitive Salary
-
Senior Account Manager
-
Salary TBC
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account Director, Publications, Opthalmology, Medical Com...
-
Highly competitive salary
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Medical Writer, Rare diseases, Medical Communications age...
-
Highly competitive salary
- Senior Account Director, Publications, Women’s health, Medical C...
-
Highly competitive salary
- Client Services Director, Patient Engagement & Solutions, Lo...
-
Highly competitive salary
- Medical Writer, Women’s health, Medical Communications agency, h...
-
Highly competitive salary
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
- FREELANCE (Outside IR35) Opportunities for this week below!!!
-
Superb Day Rate
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
-
Planner
-
Salary TBC
- Pfizer/BioNTech, AZ vaccines effective against Delta COVID-19 variant after two doses
- Novavax announces further delays for regulatory filings of COVID-19 vaccine
- Novartis highlights potential of its radioligand therapy in prostate cancer at ASCO
- Positive late-stage results for Novartis’ radioligand therapy in advanced prostate cancer
- Disappointing results from CureVac’s COVID-19 vaccine as phase 2/3 study shows only 47% efficacy
- AZ, Pfizer/BioNTech COVID-19 vaccines 'highly effective' against Indian variant
- OPEN Health Starring in the Top 100 North American Healthcare Agencies of 2021
- Gilead reveals real-world data for COVID-19 drug Veklury
- EFPIA appoints Hubertus von Baumbach as president
- COUCH Health Engages Mark Duman as Chief Strategy Officer
- New data shows benefits for presymptomatic SMA patients treated with Zolgensma
- Sanofi’s oral therapy Aubagio approved in the EU for paediatric MS patients
- Diversity and inclusion in clinical trials
- J&J’s Darzalex shows ‘significant’ survival benefit in newly diagnosed multiple myeloma
- Pfizer takeover rumour ignites Amarin shares
- The rise of vertical integration in the US payer landscape
- Biogen advances Spinraza study in SMA patients treated with Novartis’ Zolgensma
- BMS’ CAR T therapy Breyanzi shows benefit in B-cell lymphoma study
PMHub
Oncosec
OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...
Latest intelligence
- The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
- By Henry Skinner, Chief Executive Officer of the AMR Action Fund...
- How early-stage clinical research is facilitating the new wave of personalised medicines
- By Jorg Taubel...
- Patient diversity in clinical trials needs to be centre stage
- By Danny Buckland...
